Plakoglobin Deficiency Protects Keratinocytes from

The armadillo family protein plakoglobin (Pg) is a well-characterized component of anchoring junctions, where it functions to mediate cell–cell adhesion and maintain epithelial tissue integrity. Although its closest homolog b-catenin acts in the Wnt signaling pathway to dictate cell fate and promote proliferation and survival, the role of Pg in these processes is not well understood. Here, we investigate how Pg affects the survival of mouse keratinocytes by challenging both Pg-null cells and their heterozygote counterparts with apoptotic stimuli. Our results indicate that Pg deletion protects keratinocytes from apoptosis, with null cells exhibiting delayed mitochondrial cytochrome c release and activation of caspase-3. Pg-null keratinocytes also exhibit increased messenger RNA and protein levels of the anti-apoptotic molecule Bcl-XL compared to heterozygote controls. Importantly, reintroduction of Pg into the null cells shifts their phenotype towards that of the Pg þ /� keratinocytes, providing further evidence that Pg plays a direct role in regulating cell survival. Taken together, our results suggest that in addition to its adhesive role in epithelia, Pg may also function in contrast to the prosurvival tendencies of b-catenin, to potentiate death in cells damaged by apoptotic stimuli, perhaps limiting the potential for the propagation of mutations and cellular transformation.

[1]  A. de Bruin,et al.  Pemphigus vulgaris identifies plakoglobin as key suppressor of c‐Myc in the skin , 2006, The EMBO journal.

[2]  Michael D. Schneider,et al.  Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. , 2006, The Journal of clinical investigation.

[3]  F. Chen,et al.  The Differentiation-dependent Desmosomal Cadherin Desmoglein 1 Is a Novel Caspase-3 Target That Regulates Apoptosis in Keratinocytes* , 2006, Journal of Biological Chemistry.

[4]  Huimin Xie,et al.  Stabilized β-Catenin Extends Thymocyte Survival by Up-Regulating Bcl-xL , 2005, The Journal of Immunology.

[5]  L. Godsel,et al.  Mechanisms of Plakoglobin-dependent Adhesion , 2005, Journal of Biological Chemistry.

[6]  C. Nguyên,et al.  Differential roles for the coactivators CBP and p300 on TCF/β-catenin-mediated survivin gene expression , 2005, Oncogene.

[7]  K. Green,et al.  Plakoglobin suppresses keratinocyte motility through both cell-cell adhesion-dependent and -independent mechanisms. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  K. Green,et al.  Regulation of desmosome assembly and adhesion. , 2004, Seminars in cell & developmental biology.

[9]  Ping Ji,et al.  Translocation Products in Acute Myeloid Leukemia Activate the Wnt Signaling Pathway in Hematopoietic Cells , 2004, Molecular and Cellular Biology.

[10]  M. Duñach,et al.  Tyrosine Phosphorylation of Plakoglobin Causes Contrary Effects on Its Association with Desmosomes and Adherens Junction Components and Modulates β-Catenin-Mediated Transcription , 2003, Molecular and Cellular Biology.

[11]  P. Hu,et al.  Keratinocyte adherens junctions initiate nuclear signaling by translocation of plakoglobin from the membrane to the nucleus. , 2003, The Journal of investigative dermatology.

[12]  H. Clevers,et al.  Survivin and molecular pathogenesis of colorectal cancer , 2003, The Lancet.

[13]  Hans Clevers,et al.  Wnt Signaling Controls the Phosphorylation Status of β-Catenin* , 2002, The Journal of Biological Chemistry.

[14]  F. van Roy,et al.  Protein Binding and Functional Characterization of Plakophilin 2 , 2002, The Journal of Biological Chemistry.

[15]  F. Miró,et al.  The Transcriptional Factor Tcf-4 Contains Different Binding Sites for β-Catenin and Plakoglobin* , 2002, The Journal of Biological Chemistry.

[16]  B. Boman,et al.  Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. , 2001, Cancer research.

[17]  A. de Bruin,et al.  A Central Role for the Armadillo Protein Plakoglobin in the Autoimmune Disease Pemphigus Vulgaris , 2001, The Journal of cell biology.

[18]  U. Rodeck,et al.  Epidermal Growth Factor Receptor-dependent Control of Keratinocyte Survival and Bcl-xL Expression through a MEK-dependent Pathway* , 2001, The Journal of Biological Chemistry.

[19]  M. Hengartner The biochemistry of apoptosis , 2000, Nature.

[20]  A. Crosby,et al.  Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease) , 2000, The Lancet.

[21]  Kathleen R. Cho,et al.  γ-Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin , 2000, Genes & Development.

[22]  R. Lavker,et al.  Plakoglobin Suppresses Epithelial Proliferation and Hair Growth in Vivo , 2000, The Journal of cell biology.

[23]  M. Pasdar,et al.  Plakoglobin Regulates the Expression of the Anti-apoptotic Protein BCL-2* , 2000, The Journal of Biological Chemistry.

[24]  J. Schalken,et al.  Changes in cadherin‐catenin complexes in the progression of human bladder carcinoma , 1999 .

[25]  H. Schwarz,et al.  Desmosomal localization of beta-catenin in the skin of plakoglobin null-mutant mice. , 1999, Development.

[26]  E. Fuchs,et al.  De Novo Hair Follicle Morphogenesis and Hair Tumors in Mice Expressing a Truncated β-Catenin in Skin , 1998, Cell.

[27]  K. Green,et al.  Contributions of extracellular and intracellular domains of full length and chimeric cadherin molecules to junction assembly in epithelial cells. , 1998, Journal of cell science.

[28]  E. Schwarz,et al.  Reduced gene expression of E-cadherin and associated catenins in human cervical carcinoma cell lines. , 1997, Cancer letters.

[29]  K. Green,et al.  Roles of plakoglobin end domains in desmosome assembly. , 1997, Journal of cell science.

[30]  R Kemler,et al.  Embryonic heart and skin defects in mice lacking plakoglobin. , 1996, Developmental biology.

[31]  B. Geiger,et al.  Suppression of tumorigenicity by plakoglobin: an augmenting effect of N- cadherin , 1996, The Journal of cell biology.

[32]  E. Gelmann,et al.  Alterations in β-Catenin Phosphorylation and Plakoglobin Expression in Human Breast Cancer Cells , 1994 .

[33]  W. Franke,et al.  Molecular cloning and amino acid sequence of human plakoglobin, the common junctional plaque protein. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Sheffield,et al.  A solid-phase method for the quantitation of protein in the presence of sodium dodecyl sulfate and other interfering substances. , 1987, Analytical biochemistry.

[35]  N. Protonotarios,et al.  Cardiac abnormalities in familial palmoplantar keratosis. , 1986, British heart journal.

[36]  R. Hynes,et al.  Plakoglobin: A protein common to different kinds of intercellular adhering junctions , 1986, Cell.